SCHEMBL1349353

SCHEMBL1349353

C=C(Cc1ncc(Cl)nc1Cl)C(=O)OCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
XPO1 O14980 1/20 0.35
CASP1 P29466 1/20 0.35
ALDH1A1 P00352 7/20 0.34
MAPT P10636 4/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
XBP1 P17861 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TLR9 Q9NR96 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
KDM4E B2RXH2 2/20 0.33
DGAT1 O75907 1/20 0.33
RAB9A P51151 1/20 0.33
HPGD P15428 1/20 0.32
LMNA P02545 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17908109 0.81 S1PR2 (0.32) MAPKAPK2ALDH1A1TDP1
SCHEMBL12130919 0.74 MAPKAPK2 (0.33) MAPKAPK2ALDH1A1
SCHEMBL4019648 0.74 MAPKAPK2 (0.35) MAPKAPK2ALDH1A1NPC1MAPK1RAB9A
SCHEMBL30398825 0.74 ALDH1A1 (0.40) MAPKAPK2NPSR1ALDH1A1MAPTNPC1
SCHEMBL19816108 0.74 ALDH1A1 (0.40) MAPKAPK2NPSR1ALDH1A1MAPTNPC1
SCHEMBL17372766 0.73 DPP4 (0.34) XPO1ALDH1A1MAPTNPC1RAB9A
SCHEMBL18832296 0.72 CASP1 (0.37) NPSR1XPO1CASP1ALDH1A1MAPT
SCHEMBL28048176 0.72 AGBL2 (0.42) MAPKAPK2ALDH1A1MAPTMAPK1KDM4E
SCHEMBL18832311 0.71 PDE4D (0.42) NPSR1XPO1CASP1ALDH1A1MAPT
SCHEMBL16606973 0.70 RAB9A (0.40) ALDH1A1NPC1MAPK1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396337-B1 PREPARATION AND USE OF ZINC-AMIDES UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-13 EP claimed
EP-2396337-A1 PRODUCTION AND USE OF ZINC AMIDES Ludwig-Maximilians-Universität München (DE) 2011-12-21 EP claimed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US claimed
WO-2010092096-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2010-08-19 WO claimed
US-9688701-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2017-06-27 US disclosed
US-9688701-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2017-06-27 US disclosed
US-9688701-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2017-06-27 US disclosed
US-20160215000-A1 Production And Use Of Zinc Amides UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-28 US disclosed
US-20160215000-A1 Production And Use Of Zinc Amides UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-28 US disclosed
US-20160215000-A1 Production And Use Of Zinc Amides UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-28 US disclosed
EP-2396337-B1 PREPARATION AND USE OF ZINC-AMIDES UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-13 EP disclosed
EP-2396337-B1 PREPARATION AND USE OF ZINC-AMIDES UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-13 EP disclosed
US-9334237-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2016-05-10 US disclosed
US-9334237-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2016-05-10 US disclosed
WO-2015047124-A1 NOVEL CHEMICAL COMPOUNDS DERIVED FROM 2,4-DIAMINO-1,3,5-TRIAZINE FOR THE PROPHYLAXIS AND TREATMENT OF HUMAN AND ANIMAL DISEASES Общество с ограниченной ответственностью "Молекулярные Технологии" 2015-04-02 WO disclosed
EP-2396337-A1 PRODUCTION AND USE OF ZINC AMIDES Ludwig-Maximilians-Universität München (DE) 2011-12-21 EP disclosed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US disclosed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US disclosed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US disclosed
WO-2010092096-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160215000-A1 Production And Use Of Zinc Amides SCLY, CBR3, SCO2 MAPKAPK2 3682/4885NPSR1 149/4885XPO1 3160/4885
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES GLRX3, SCLY, SFXN1 MAPKAPK2 4212/4885NPSR1 280/4885XPO1 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.